Inventor · disambiguated record
Christine Esau
Also filed as: BENNETT C FRANK · ESAU CHRISTINE · ESAU CHRISTINE E
18 granted patents·7 pending applications·308 citations·filing 2004–2023
94Inventor score
Files withREGULUS THERAPEUTICS INC8ARCTURUS THERAPEUTICS INC5BENNETT C FRANK3ESAU CHRISTINE3GENEVANT SCIENCES GMBH2
Top patents by PatentIndex Score
25 records- 0199US7683036B2Oligomeric compounds and compositions for use in modulation of small non-coding RNAsREGULUS THERAPEUTICS INC·Filed 2004·Granted Mar 23, 2010·182 cites·40 claims
- 0295US8129515B2Oligomeric compounds and compositions for the use in modulation of microRNAsESAU CHRISTINE·Filed 2007·Granted Mar 6, 2012·60 cites·27 claims
- 0394US8211867B2Targeting microRNAs for the treatment of liver cancerBENNETT C FRANK·Filed 2008·Granted Jul 3, 2012·23 cites·27 claims
- 0493US9127272B2Oligomeric compounds and compositions for the use in modulation of target nucleic acidsESAU CHRISTINE·Filed 2012·Granted Sep 8, 2015·17 cites·9 claims
- 0592US8809294B2Method of inhibiting miR-33 using a modified oligonucleotideBENNETT C FRANK·Filed 2012·Granted Aug 19, 2014·7 cites·25 claims
- 0688US9598693B2Oligomeric compounds and compositions for the use in modulation of micrornasIONIS PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·3 cites·15 claims
- 0784US9506062B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·3 cites·24 claims
- 0884US8680067B2Targeting microRNAs for the treatment of liver cancerBENNETT C FRANK·Filed 2012·Granted Mar 25, 2014·5 cites·25 claims
- 0983US9150857B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2014·Granted Oct 6, 2015·4 cites·26 claims
- 1082US10301627B2Targeting microRNAs for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·2 cites·24 claims
- 1178US7998677B2MicroRNA detectionREGULUS THERAPEUTICS INC·Filed 2009·Granted Aug 16, 2011·1 cites·16 claims
- 1272US8969314B2Methods for use in modulating miR-122aESAU CHRISTINE·Filed 2006·Granted Mar 3, 2015·1 cites·37 claims
- 1365US11912997B2RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2023·Granted Feb 27, 2024·0 cites·30 claims
- 1465US11685921B2Molecules and agents for treating hepatitis B virusARCTURUS THERAPEUTICS INC·Filed 2019·Granted Jun 27, 2023·0 cites·11 claims
- 1563US9845470B2Targeting microRNAS for the treatment of liver cancerREGULUS THERAPEUTICS INC·Filed 2016·Granted Dec 19, 2017·0 cites·25 claims
- 1656US2023001021A1Ornithine transcarbamylase (otc) constructs and methods of using the samePRIEVE MARY·Filed 2020·Application pending·0 cites
- 1755US2022387600A1Conjugates and methods for treating liver fibrosisGENEVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 1855US2009203893A1Antisense compounds having enhanced anti-microrna activityREGULUS THERAPEUTICS LLC·Filed 2006·Application pending·0 cites
- 1954US2022288214A1Conjugates and methods for treating acromegalyGENEVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 2051US10961535B2Compositions and agents against hepatitis B virus and uses thereofARCTURUS THERAPEUTICS INC·Filed 2018·Granted Mar 30, 2021·0 cites·18 claims
- 2151US2017137821A1Molecules and agents for treating hepatitis b virusARCTURUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2248US12083224B2Lipid particles for nucleic acid deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Sep 10, 2024·0 cites·17 claims
- 2348US9994842B2Methods for use in modulating miR-122AREGULUS THERAPEUTICS INC·Filed 2015·Granted Jun 12, 2018·0 cites·18 claims
- 2447US2015247142A1Antisense compounds having enhanced anti-microrna activityREGULUS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2543US2017016000A1Compositions and agents against hepatitis b virus and uses thereofARCTURUS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christine Esau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →